BRPI0410440A - derivados de benzotiazol como ligandos de receptor de adenosina - Google Patents
derivados de benzotiazol como ligandos de receptor de adenosinaInfo
- Publication number
- BRPI0410440A BRPI0410440A BRPI0410440-4A BRPI0410440A BRPI0410440A BR PI0410440 A BRPI0410440 A BR PI0410440A BR PI0410440 A BRPI0410440 A BR PI0410440A BR PI0410440 A BRPI0410440 A BR PI0410440A
- Authority
- BR
- Brazil
- Prior art keywords
- optionally substituted
- lower alkyl
- oxa
- aromatic heterocycle
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"DERIVADOS DE BENZOTIAZOL COMO LIGANDOS DE RECEPTOR DE ADENOSINA". A invenção diz respeito aos compostos da fórmula geral I em que R¬ 1¬ é 1,4-dioxepanila ou tetraidropiran-4-ila; R¬ 2¬ é N(R)-(CH~ 2~)~ n~-heterociclo não-aromático de 5 ou 6 membros, opcionalmente substituído por um ou mais substituintes, selecionados do grupo que consiste em alquila inferior ou NR¬ 2¬, ou -(CH~ 2~)~ n~-heterociclo não aromático de 5 ou 6 membros, opcionalmente substituído por -(CH~ 2~)~ n~-OH, alquila inferior, alcóxi inferior, ou é (CH~ 2~)~ n~-heterociclo aromático de 5 ou 6 membros, opcionalmente substituído por alquila inferior, alcóxi inferior, halógeno, halógeno-alquila inferior, - CH~ 2~N(R)(CH~ 2~)~ 2~0CH~ 3~, -N(R)(CH~ 2~)~ 2~0CH~ 3~,-CH~ 2~-morfolinila ou -CH~ 2~-Pirrolidinila ou é (CH~ 2)~ n~-cicloalquila, opcionalmente substituída por hidróxi, ou é -N(R)cicloalquila, opcionalmente substituída por hidróxi ou alquila inferior, ou é fenila, opcionalmente substituída por alcóxi inferior, halógeno, halógenoalquila inferior, alquila inferior, -CH~ 2~-Pirrolidin-l-ila, -CH~ 2~-Morfolinila, CH~ 2~N(R)(CH~ 2~)~ 2~0CH~ 3~ ou -CH~ 2~-N(R)C(O)-alquila inferior, ou é 1,4-dioxa-8-aza-espiro¢4.5!decano, ou é 2-oxa-5-aza-biciclo¢2.2.1!heptano, ou é l-oxa-8aza-espiro¢4.5!decano, ou é -N(R)-7-oxa-biciclo¢2.2.1!hept-2-ila, ou é 2-azabiciclo¢2.2.2!decano; R é hidrogênio ou alquila inferior; n é O ou 1; e sais de adição de ácido farmaceuticamente aceitáveis destes para o tratamento de doenças, que relacionam ao receptor A2A.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03011039 | 2003-05-19 | ||
| PCT/EP2004/005178 WO2005000842A1 (en) | 2003-05-19 | 2004-05-14 | Benzothiazole derivatives as adenosine receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0410440A true BRPI0410440A (pt) | 2006-06-06 |
Family
ID=33442729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0410440-4A BRPI0410440A (pt) | 2003-05-19 | 2004-05-14 | derivados de benzotiazol como ligandos de receptor de adenosina |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7371748B2 (pt) |
| EP (1) | EP1636223B1 (pt) |
| JP (1) | JP4444290B2 (pt) |
| KR (1) | KR100859886B1 (pt) |
| CN (1) | CN100528871C (pt) |
| AR (1) | AR044362A1 (pt) |
| AT (1) | ATE389652T1 (pt) |
| AU (1) | AU2004251814B2 (pt) |
| BR (1) | BRPI0410440A (pt) |
| CA (1) | CA2524366C (pt) |
| CL (1) | CL2004001067A1 (pt) |
| CO (1) | CO5630031A2 (pt) |
| DE (1) | DE602004012555T2 (pt) |
| DK (1) | DK1636223T3 (pt) |
| ES (1) | ES2301991T3 (pt) |
| HK (1) | HK1092469A1 (pt) |
| HR (1) | HRP20080207T3 (pt) |
| IL (1) | IL171686A (pt) |
| MX (1) | MXPA05012360A (pt) |
| NO (1) | NO20055150L (pt) |
| NZ (1) | NZ543074A (pt) |
| PL (1) | PL1636223T3 (pt) |
| PT (1) | PT1636223E (pt) |
| RU (1) | RU2351597C2 (pt) |
| SI (1) | SI1636223T1 (pt) |
| TW (1) | TW200505882A (pt) |
| WO (1) | WO2005000842A1 (pt) |
| ZA (1) | ZA200509294B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008052930A2 (en) * | 2006-11-03 | 2008-05-08 | F. Hoffmann-La Roche Ag | Preparation of 4-alk0xy-7- (tetrahydropyran-4-yl) benzothiazol-2-amine derivatives |
| IL272284B2 (en) | 2017-08-01 | 2024-01-01 | Merck Patent Gmbh | History of thiazolopyridines, their preparation and pharmaceutical preparations containing them |
| JP7287952B2 (ja) | 2017-08-21 | 2023-06-06 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | アデノシン受容体アンタゴニストとしてのベンズイミダゾール誘導体 |
| WO2019038214A1 (en) | 2017-08-21 | 2019-02-28 | Merck Patent Gmbh | QUINOXALINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS |
| WO2019141096A1 (zh) * | 2018-01-19 | 2019-07-25 | 四川科伦博泰生物医药股份有限公司 | 取代脲类化合物及其制备方法和用途 |
| CN112867715B (zh) | 2018-10-25 | 2024-03-05 | 默克专利股份公司 | 作为腺苷受体拮抗剂的5-氮杂吲唑衍生物 |
| KR20210083293A (ko) | 2018-10-25 | 2021-07-06 | 메르크 파텐트 게엠베하 | 아데노신 수용체 안타고니스트로서의 5-아자인다졸 유도체 |
| AR117844A1 (es) | 2019-01-22 | 2021-09-01 | Merck Patent Gmbh | Derivados de tiazolopiridina como antagonistas del receptor de adenosina |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1234358C (zh) * | 2000-06-21 | 2006-01-04 | 弗·哈夫曼-拉罗切有限公司 | 苯并噻唑衍生物 |
| EP1450796B1 (en) * | 2001-11-27 | 2008-04-09 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives |
| US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
| US6734179B2 (en) * | 2001-12-12 | 2004-05-11 | Hoffmann-La Roche Inc. | Benzothiazoles |
| PL378343A1 (pl) * | 2003-01-13 | 2006-03-20 | F. Hoffmann-La Roche Ag | Pochodne benzoksazolu i ich zastosowanie jako ligandów receptora adenozyny |
-
2004
- 2004-05-14 PT PT04732950T patent/PT1636223E/pt unknown
- 2004-05-14 SI SI200430668T patent/SI1636223T1/sl unknown
- 2004-05-14 EP EP04732950A patent/EP1636223B1/en not_active Expired - Lifetime
- 2004-05-14 AT AT04732950T patent/ATE389652T1/de active
- 2004-05-14 WO PCT/EP2004/005178 patent/WO2005000842A1/en active IP Right Grant
- 2004-05-14 BR BRPI0410440-4A patent/BRPI0410440A/pt not_active Application Discontinuation
- 2004-05-14 NZ NZ543074A patent/NZ543074A/en unknown
- 2004-05-14 JP JP2006529816A patent/JP4444290B2/ja not_active Expired - Fee Related
- 2004-05-14 KR KR1020057021945A patent/KR100859886B1/ko active IP Right Grant
- 2004-05-14 DK DK04732950T patent/DK1636223T3/da active
- 2004-05-14 RU RU2005139527/04A patent/RU2351597C2/ru not_active IP Right Cessation
- 2004-05-14 ES ES04732950T patent/ES2301991T3/es not_active Expired - Lifetime
- 2004-05-14 AU AU2004251814A patent/AU2004251814B2/en not_active Ceased
- 2004-05-14 DE DE602004012555T patent/DE602004012555T2/de not_active Expired - Lifetime
- 2004-05-14 TW TW093113590A patent/TW200505882A/zh unknown
- 2004-05-14 MX MXPA05012360A patent/MXPA05012360A/es active IP Right Grant
- 2004-05-14 CN CNB2004800135624A patent/CN100528871C/zh not_active Expired - Fee Related
- 2004-05-14 PL PL04732950T patent/PL1636223T3/pl unknown
- 2004-05-14 CA CA2524366A patent/CA2524366C/en not_active Expired - Fee Related
- 2004-05-17 AR ARP040101684A patent/AR044362A1/es not_active Application Discontinuation
- 2004-05-17 CL CL200401067A patent/CL2004001067A1/es unknown
- 2004-05-17 US US10/847,558 patent/US7371748B2/en not_active Expired - Fee Related
-
2005
- 2005-10-31 IL IL171686A patent/IL171686A/en active IP Right Grant
- 2005-11-03 NO NO20055150A patent/NO20055150L/no not_active Application Discontinuation
- 2005-11-16 ZA ZA200509294A patent/ZA200509294B/en unknown
- 2005-11-16 CO CO05116289A patent/CO5630031A2/es not_active Application Discontinuation
-
2006
- 2006-11-29 HK HK06113066.6A patent/HK1092469A1/xx not_active IP Right Cessation
-
2008
- 2008-05-08 HR HR20080207T patent/HRP20080207T3/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2763601T3 (es) | Derivados de heteroarilo y sus usos | |
| CN104592211B (zh) | 联苯类化合物及其用途 | |
| CA2917198C (en) | Fused piperidine amides as modulators of ion channels | |
| JP2010536887A5 (pt) | ||
| BRPI0409986A (pt) | derivados de pirimidina fundida com atividade de crf | |
| AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
| JP3545416B2 (ja) | フペルジンａ誘導体、その製造およびその使用 | |
| CN105503862A (zh) | 流感病毒复制抑制剂 | |
| AU2011367809A1 (en) | Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) | |
| BRPI0410440A (pt) | derivados de benzotiazol como ligandos de receptor de adenosina | |
| WO2007122634A3 (en) | Pyrimidinediones as tyrosine kinase inhibitors | |
| WO2016024233A1 (en) | Inhibitors of tryptophan dioxygenases (ido1 and tdo) and their use in therapy | |
| CA3221939A1 (en) | N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channels | |
| BRPI0507054A (pt) | bloqueadores do canal de cálcio tipo n | |
| JP2023000996A (ja) | プロテアーゼ阻害剤としてのケトアミド誘導体 | |
| BRPI0417520A (pt) | 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon | |
| KR20220143116A (ko) | 조합 요법을 포함하는 setd2 억제제 및 관련 방법 및 용도 | |
| WO2018209239A1 (en) | Potent agelastatin derivatives as modulators for cancer invasion and metastasis | |
| CN110272425B (zh) | 吡啶酰基八氢吡咯并[3,4-c]吡咯衍生物及其用途 | |
| NO20062616L (no) | Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder | |
| BR0306148A (pt) | Compostos, composições farmacêuticas, e, uso de um composto | |
| AR042480A1 (es) | Derivados de la quinazolina para el trtamiento del crecimiento celular anormal | |
| AR066956A1 (es) | Derivados de [1,10]-fenantrolina, composiciones farmaceuticas que los contienen, metodo de preparacion y uso para el tratamiento de enfermedades neurodegenerativas o hematologicas. | |
| PL378343A1 (pl) | Pochodne benzoksazolu i ich zastosowanie jako ligandów receptora adenozyny | |
| DE60041880D1 (de) | Verfahren zur verbesserung der chemotherapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |